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Purpose: We investigated the characteristics of lung allocation and outcomes of lung transplant (LTx) according to the Korean ur-
gency status.
Materials and Methods: LTx registration in the Korean Organ Transplantation Registry (KOTRY) began in 2015. From 2015 to 
June 2017, 86 patients who received LTx were enrolled in KOTRY. After excluding one patient who received a heart-lung trans-
plant, 85 were included. Subjects were analyzed according to the Korean urgency status.
Results: Except for Status 0, urgency status was classified based on partial pressure of oxygen in arterial blood gas analysis and 
functional status in 52 patients (93%). The wait time for lung allograft was well-stratified by urgency (Status 0, 46.5±59.2 days; Sta-
tus 1, 104.4±98.2 days; Status 2 or 3, 132.2±118.4 days, p=0.009). Status 0 was associated with increased operative times and higher 
intraoperative blood transfusion. Status 0 was associated with prolonged extracorporeal membrane oxygenation use, postopera-
tive bleeding, and longer mechanical ventilation after operation. Survival of Status 0 patients seemed worse than that of non-Sta-
tus 0 patients, although differences were not significant.
Conclusion: The Korean urgency classification for LTx is determined by using very limited parameters and may not be a true re-
flection of urgency. Status 0 patients seem to have poor outcomes compared to the other urgency status patients, despite having 
the highest priority for donor lungs. Further multi-center and nationwide studies are needed to revise the lung allocation system 
to reflect true urgency and provide the best benefit of lung transplantation.
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INTRODUCTION
Lung transplant (LTx) has been accepted as a standard treat-
ment for patients with end-stage lung disease.1 The first LTx in 
Korea was performed in July 1996.2 Since the outbreak of lung 
injuries caused by humidifier disinfectants in 2010,3 the number 
of LTx has been rapidly increasing in Korea, from 18 cases in 
2010 to 93 cases in 2017. However, the number of patients on 
the waitlist for LTx has also been increasing, from 39 patients 
in 2010 to 168 patients in 2017.4 Due to organ donor shortages 
and increasing number of transplant candidates, some candi-
dates may inevitably die while on the waitlist, without getting 
a chance to receive LTx. For this reason, efficient allocation sys-
tems for donor lungs are of great importance in Korea.
Each country has its own allocation system. The lung alloca-
tion score (LAS) system is the most widely used allocation sys-
tem in the world. It is based on the statistical model developed 
by analyzing the national transplant database of the United 
States,5,6 which takes into account both the urgency and the 
benefits of the transplant. In Korea, allocation system for donor 
lungs is based only on urgency of transplant. It divides patients 
into four groups according to urgency criteria, which are deter-
mined empirically. Status 0 is the most urgent status and des-
ignates hospitalized patients requiring a ventilator and/or extra-
corporeal life support. The Korean allocation system has rarely 
been evaluated and validated by large data. Previously, a single 
center retrospective study was conducted to evaluate the Ko-
rean allocation system by simulating LAS system. This study 
found that most LTx were performed in Status 0 or Status 1 pa-
tients. Status 0 patients had significantly higher LASs and poor-
er post-transplant survival rates than Status 1 patients.7 
The Korean Organ Transplant Registry (KOTRY) was estab-
lished in 2014 as a service of the Korean Centers for Disease 
Control (KCDC), and it began to resister LTx cases in 2015.8 It is 
the first nationwide multi-center registry for LTx in Korea. This 
study aimed to investigate the characteristics of donor lung al-
location using this urgency-based lung allocation system, and 
to evaluate the outcomes of LTx according to the Korean urgen-
cy status using KOTRY database.
MATERIALS AND METHODS
Korean allocation system of donor lungs
The definition of urgency status is described in Table 1.7,9 Donor 
lungs are allocated to the most urgent patients based on urgen-
cy status. When the urgency status of a transplant candidate 
changes, the institution of the candidate must inform the Ko-
rean Network for Organ Sharing (KONOS). Then, KONOS uses 
the urgency status to determine the allocation of donor lungs. 
Among patients with the same urgency status, candidates are 
selected using a scoring system that takes into account waiting 
time, blood type, presence of infectious disease, distance be-
tween the donor and recipient hospitals, age, primary lung di-
agnosis, and difference in the donor’s and recipient’s estimated 
lung volumes. 
Data source and variables
This study was approved by Institutional Review Board (IRB) 
at Severance Hospital, Yonsei University College of Medicine 
(IRB number 4-2017-0815). Patients in this study were selected 
from the LTx cohort of KOTRY. Patients who received heart-
lung transplantation were excluded. LTx cohort of KOTRY 
began in 2015, and five institutions have contributed to LTx 
registry. Written informed consent was obtained from all partic-
ipants prior to LTx at relevant institutions; therefore, the need 
Table 1. Indication and Distributions of Urgency Status of Lung Transplantation Recipients
Urgency status Indications N (%)
Status 0 Patients are connected to a ventilator or an extracorporeal membrane oxygenation 29 (34.1)
Status 1 One of the following: 47 (55.3)
1. NYHA stage IV patients with a PaO2 <55 mm Hg in room air 47 (100)
2. NYHA stage IV patients with an average pulmonary pressure >65 mm Hg or an average right atrial pressure >15 mm Hg 0 (0)
3. Cardiac index <2 L/min/m2 0 (0)
Status 2 One of the following: 6 (7.1)
1. Forced expiratory volume in 1 second <25% on pulmonary function test 1 (16.7)
2. PaO2 <60 mm Hg in room air 5 (83.3)
3. Average right atrial pressure: 10–15 mm Hg 0 (0)
4. Average pulmonary pressure: 55–65 mm Hg 0 (0)
5. Cardiac index: 2–2.5 L/min/m2 0 (0)
6. Previous lung transplantation 0 (0)
7. Previous lung volume reduction surgery 0 (0)
8. Lung cancer 0 (0)
Status 3 Patients not included in any of the conditions above, but require a lung transplant 3 (3.5)
NYHA, New York Heart Association.
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for patient consent was waived for this study. Patients who re-
ceived LTx from the beginning of the cohort to June 2017 were 
enrolled in this study. Follow-up was completed in December 
2017.
According to the urgency status of recipient at the time of LTx, 
we compared recipient and donor characteristics, operative char-
acteristics, and postoperative outcomes. Recipient character-
istics included age, sex, primary pulmonary diagnosis, intensive 
care unit (ICU) care, mechanical ventilation, extracorporeal 
membrane oxygenator (ECMO) support at the time of LTx, and 
wait time. Wait time was measured from the date of enrollment 
for LTx to the date of transplant. Donor characteristics included 
age, sex, smoking, and partial pressure of oxygen (PaO2) in the 
arterial blood/fraction of inspired oxygen ratio (P/F ratio). Op-
erative characteristics included unilateral or bilateral LTx, in-
traoperative extracorporeal life support (ECLS), operative time, 
and intraoperative transfusion. Postoperative outcomes includ-
ed measured major postoperative complications (postoperative 
ECMO use, bleeding, need for renal replacement therapy, in-
fection), length of mechanical ventilation, length of ICU stay, 
and survival.
Statistical analysis
Statistical analysis was performed using SPSS version 23.0 (IBM 
Corp, Armonk, NY, USA) and R version 3.4.4 (R Foundation for 
Statistical Computing, Vienna, Austria). Clinical variables were 
described as mean±standard deviation or median (range) for 
continuous variables, and as frequency (percentage) for cate-
gorical variables. Continuous variables were compared using 
one-way analysis of variance. Categorical variables were com-
pared using chi-squared test or Fisher’s exact test. Bonferroni 
correction was used in multiple comparisons with continuous 
and categorical variables. Survival analysis was performed us-
ing Kaplan-Meier method, and comparisons were made using 
log-rank test. p values less than 0.05 were considered statisti-
cally significant.
RESULTS
During the study period, a total of 86 patients were enrolled in 
KOTRY. After excluding one patient who received heart-lung 
transplant, 85 patients were included in this study. Twenty-nine 
Status 0 patients (34.1%) received LTx. There were 47 Status 1 
patients and six Status 2 patients who received LTx. All Status 
1 patients and 83.3% of Status 2 patients were classified based 
on the criteria of PaO2 in arterial blood gas analysis and func-
tional status (Table 1).
Patient and donor characteristics are summarized in Table 2. 
The mean age of all patients was 55.6±9.8, and 65.9% of patients 
were men. There were more male patients with Status 0 than 
with Status 1 (p=0.012). Idiopathic pulmonary fibrosis (IPF) was 
the most frequent indication for LTx in all urgency status groups. 
All Status 0 patients were under care in ICU at the time of trans-
plant. Among Status 0 patients, 28 (96.6%) and 18 (62.1%) were 
supported by mechanical ventilation and ECMO, respectively. 
The mean wait time was 87.6±93.5 days, and Status 0 patients 
had significantly shorter wait times than Status 1 patients (p= 
0.022) or Status 2/3 patients (p=0.042). There was no significant 
difference in donor characteristics based on urgency status.
Most patients received bilateral LTx. There was no difference 
in intraoperative ECLS based on urgency status. Operation times 
were significantly longer (p<0.001), and red blood cells and 
fresh frozen plasma were more frequently transfused intraop-
eratively in Status 0 patients than in Status 1 patients (p<0.001 
and p=0.014, respectively) (Table 3). Seventeen (58.6%) Status 0 
patients required postoperative ECMO, which was significantly 
higher than the number of Status 1 patients requiring ECMO 
(p=0.020). Six status 0 (20.7%) patients suffered from postop-
erative bleeding, and there was no postoperative bleeding 
among other urgency statuses. Although there was no statisti-
cal significance, Status 0 patients seemed to have longer peri-
ods of mechanical support, longer ICU and hospital stay, and 
poorer short-term survival (Table 4, Fig. 1) compared to patients 
in other urgency statuses.
DISCUSSION
In this study, we found that the urgency status for LTx in Korea 
is defined in practice by limited clinical parameters, such as 
mechanical ventilation and/or ECMO use, functional status, 
and PaO2. Additionally, most of the candidates who received 
LTx were either Status 0 or Status 1 patients. Status 0 was associ-
ated with longer operative times, higher intraoperative blood 
transfusion volumes, higher postoperative ECMO use, post-
operative bleeding, and longer postoperative ICU stay. Status 
0 patients seemed to have poorer postoperative survival.
Allocation systems differ between countries. They are based 
on the urgency, waiting time, benefits, or a combination of these 
criteria in most countries.6,7 If waiting time is used, there must 
be no disagreement. However, it is difficult to decide which pa-
tient is more urgent or who will benefit more from lung trans-
plantation. The Korean allocation system was designed to allo-
cate donor lungs based on urgency. The urgency criteria were 
created empirically by experts. The criteria were not based on 
data, and the data have not been validated. Notably, there was 
a lack of data to determine whether the urgency status in Korea 
reflects the true urgency or waitlist mortality. 
In this study, most urgency status cases, except for Status 0, 
were determined by functional status and PaO2. The criteria of 
PFT and right heart catheterization were barely used. For exam-
ple, in this system, patients with IPF and acute exacerbation 
dependent on high-flow nasal O2 therapy had no priority over 
stable patients with chronic obstructive pulmonary disease and 
hypoxia being treated with long-term oxygen therapy. These pa-
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tients with acute exacerbation of IPF had a higher chance of de-
teriorating to Status 0 or dying before they received LTx. This 
finding corresponded with a previous study of LAS simulation 
at a Korean LTx center. Status 1 patients had a wide range of LAS 
from 25 to 88.7
Before the introduction of LAS in the United States, waiting 
Table 3. Operative Characteristics
Total (n=85) Status 0 (n=29) Status 1 (n=47) Status 2/3 (n=9) p value
Bilateral 82 (96.5) 29 (100) 45 (95.7) 8 (88.9) 0.201
Intraoperative ECLS 0.336
No support 2 (2.4) 0 (0.0) 1 (2.1) 1 (11.1)
CPB 26 (30.6) 10 (34.5) 15 (31.9) 1 (11.1)
ECMO 57 (67.0) 19 (65.5) 31 (66.0) 7 (77.8)
Operative time (min) 498±143 594±145* 442±101* 478±178 <0.001
Intraoperative blood transfusion
pRBC (U) 7.6±4.9 10.4±5.2*,† 6.2±4.0* 5.5±4.0*,† <0.001
Platelet concentrate 4.9±5.7 6.3±6.6 4.6±5.1 2.0±4.2 0.115
Platelet apheresis 0.3±0.8 0.4±0.9 0.0±0.4* 1.8±0.6* 0.009
FFP (U) 4.1±4.0 5.7±4.5* 3.0±2.9* 4.5±5.6 0.017
Cryoprecipitate 2.0±5.8 3.8±8.9 1.0±3.0 0.8±2.6 0.097
ECLS, extracorporeal life support; CPB, cardiopulmonary bypass; ECMO, extracorporeal membrane oxygenation; pRBC, packed red blood cells; FFP, fresh frozen 
plasma.
Values are presented as mean±standard deviation or n (%) unless otherwise indicated.
*,†There were significant differences in multiple comparison analysis with Bonferroni correction (p<0.05).
Table 2. Baseline Characteristics of Patients
Total (n=85) Status 0 (n=29) Status 1 (n=47) Status 2/3 (n=9) p value
Age (yr) 55.6±9.8 56.2±10.7 54.0±9.3 61.6±7.4 0.097
Male 56 (65.9) 25 (86.2)* 24 (51.1)* 7 (77.8) 0.005
Primary diagnosis 0.206
IPF 45 (52.9) 14 (48.3) 26 (55.3) 5 (55.6)
CTD-ILD 14 (16.5) 4 (13.8) 9 (19.1) 1 (11.1)
Other fibrosis 2 (2.4) 1 (3.4) 1 (2.1) 0 (0)
BOS after HSCT 7 (8.2) 2 (6.9) 4 (8.5) 1 (11.1)
COPD (emphysema) 4 (4.7) 2 (6.9) 0 (0) 2 (22.2)
Bronchiectasis 3 (3.5) 0 (0) 3 (6.4) 0 (0)
IPAH 1 (1.2) 0 (0) 1 (2.1) 0 (0)
LAM 1 (1.2) 0 (0) 1 (2.1) 0 (0)
ARDS 8 (9.4) 6 (20.7) 2 (4.3) 0 (0)
ICU care 34 (40.0) 29 (100.0)*,† 4 (8.5)* 1 (11.1)† <0.001
MV 28 (32.9) 28 (96.6)*,† 0 (0)* 0 (0)† <0.001
Duration of MV (day) [median (range)] - 18.5 (1–60) - -
ECMO 18 (21.2) 18 (62.1)*,† 0 (0)* 0 (0)† <0.001
Duration of ECMO (day) [median (range)] - 11.5 (1–45) - -
Wait time (day) 87.6±93.5 46.5±59.2*,† 104.4±98.2* 132.2±118.4† 0.009
Donor characteristics
Age (yr) 39.7±13.0 39.6±12.4 38.9±13.3 44.0±13.7 0.569
Male 52 (61.2) 19 (65.5) 27 (57.4) 6 (66.7) 0.734
Smoking 35 (41.2) 10 (34.5) 22 (46.8) 3 (33.3) 0.501
P/F ratio 468.8±98.8 443.2±129.3 487.9±69.2 451.0±107.5 0.136
IPF, idiopathic pulmonary fibrosis; CTD-ILD, connective tissue disease-related interstitial lung disease; BOS, bronchiolitis obliterans syndrome; HSCT, hematopoi-
etic stem cell transplantation; COPD, chronic obstructive pulmonary disease; IPAH, idiopathic pulmonary artery hypertension; LAM, lymphangioleiomyomatosis; 
ARDS, acute respiratory distress syndrome; ICU, intensive care unit; MV, mechanical ventilation; ECMO, extracorporeal membrane oxygenation; P/F ratio, partial 
pressure of oxygen in the arterial blood/fraction of inspired oxygen ratio.
Values are presented as mean±standard deviation or n (%) unless otherwise indicated.
*,†There were significant differences in multiple comparison analysis with Bonferroni correction (p<0.05).
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time was used for allocation. Due to the high waitlist mortality, 
especially for IPF patients, the need for a new allocation system 
was raised. The LAS system, as a new allocation system, was de-
signed to allocate donor lungs based on measures of medical 
urgency while avoiding futile transplants. The study reviewed 
3103 cases of LTx that were recorded in the U.S. Register Organ 
Procurement & Transplantation Network.5,6 The statistical 
model for waitlist mortality (medical urgency) and post-trans-
plant survival (benefit) were developed based on clinical data. 
LAS has been revised by clinical data. In LAS system, predict-
ed waitlist urgency and posttransplant survival are calculated 
using various clinical parameters such as age, height, weight, 
lung diagnosis, functional status, diabetes, need for assisted 
ventilation, O2 requirement, PFT, right heart catheterization, 
partial pressure of carbon dioxide (PCO2), serum creatinine lev-
els, and serum bilirubin levels.10 After introduction of LAS, re-
duction of waitlist mortality was observed.6 The process of es-
tablishing LAS system might serve as an educational example 
for the Korean allocation system. To revise this system, we must 
review our clinical data to evaluate waitlist mortality according 
to urgency status, and evaluate parameters that are related to 
waitlist mortality.
Based on data from the United Network for Organ Sharing, 
among a total of 15934 LTx performed between 1987 and 2008, 
only 586 patients (3.7%) were on mechanical ventilation and 51 
patients (0.3%) were on ECMO.11 Recently, ECMO was reported 
to be used in up to 13% of all LTx in high-volume centers in the 
United States.12,13 However, in this study, 34.1% of patients were 
Status 0 and dependent on mechanical ventilation or ECMO 
preoperatively (32.9% on mechanical ventilation and 21.2% on 
ECMO). Status 0 patients had more intra- and postoperative 
complications and seemed to have poorer postoperative sur-
vival compared to other groups (p=0.342). In a previous single-
center study, Status 0 was significantly associated with poorer 
posttransplant survival than Status 1 (p<0.001).7 Currently, Sta-
tus 0 has the highest priority for a donor lung, but it might have 
worse prognosis after transplantation than other urgency status 
designations. This study has revealed the need for an attempt to 
reduce lung transplantation in Status 0 patients.
This study had several limitations. First, this was a relatively 
small retrospective study with a short follow-up period. Howev-
er, this was the first and only multi-institutional study that at-
tempted to evaluate the Korean lung allocation system using 
nationwide LTx cohorts in Korea. As KOTRY study continues to 
enroll LTx patients and accumulate more data, KOTRY should 
help to better elucidate the problems faced in lung donor allo-
cation and to revise the allocation system in the future. Second, 
this study cohort did not include patients who died while on 
the waitlist. Therefore, we could not find related parameters to 
predict waitlist mortality (i.e., urgency). Cooperation between 
lung transplantation centers is needed to find parameters re-
lated to waitlist mortality and to revise urgency criteria to better 
reflect true urgency.
In conclusion, the Korean urgency classification for LTx is 
determined using very limited parameters, and may not be a 
true reflection of urgency. Despite having the highest priority 
Table 4. Post-Operative Outcomes
Total (n=85) Status 0 (n=29) Status 1 (n=47) Status 2/3 (n=9) p value
Postoperative ECMO use 31 (36.5) 17 (58.6)* 12 (25.5)* 2 (22.2) 0.009
Postoperative bleeding 6 (7.1) 6 (20.7)* 0 (0)* 0 (0) 0.003
Renal replacement therapy 13 (15.3) 7 (24.1) 4 (8.5) 2 (22.2) 0.114
Infection 27 (31.8) 11 (37.9) 14 (29.8) 2 (22.2) 0.615
MV day 11.5±20.8 20.1±28.6 9.7±12.1 11.5±20.8 0.098
ICU stay 14.3±12.8 18.4±13.9 11.2±11.0 17.4±15.0 0.044
Hospital stay 56.0±61.9 70.7±86.4 44.1±37.2 70.8±65.8 0.145
In-hospital mortality 13 (15.3) 7 (24.1) 6 (12.8) 0 (0) 0.172
90-day mortality 11 (12.9) 7 (24.1) 4 (8.5) 0 (0) 0.091
ECMO, extracorporeal membrane oxygenation; MV, mechanical ventilation; ICU, intensive care unit.
Values are presented as mean±standard deviation or n (%) unless otherwise indicated.
*There were significant differences in multiple comparison analysis with Bonferroni correction (p<0.05).
Fig. 1. Survival curves of Status 0 and non-Status 0 patients.
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for donor lungs, Status 0 patients seem to have poor outcomes 
compared to other urgency status patients. Further multi-cen-
ter and nationwide studies are needed to revise the lung alloca-
tion system to reflect true urgency and to provide the best ben-
efit of lung transplantation.
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